Clinical Trial Detail

NCT ID NCT02366949
Title Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

BAY1217389 + Paclitaxel

Paclitaxel

Age Groups: adult senior

No variant requirements are available.